Antigen–specific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytes
暂无分享,去创建一个
S. Rowland-Jones | R. Phillips | P. Goulder | A. Sewell | T. Dong | D. Price | R. Tan | R. Phillips
[1] R. Phillips,et al. Antagonism of cytotoxic T lymphocyte‐mediated lysis by natural HIV‐1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides , 1997, European journal of immunology.
[2] Nancy Sullivan,et al. CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro , 1997, The Journal of experimental medicine.
[3] R P Johnson,et al. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms , 1997, Journal of virology.
[4] P. Klenerman,et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[6] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[7] A. Fauci,et al. CD8+ T-cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages , 1996 .
[8] Anthony S. Fauci,et al. Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.
[9] V. Harden,et al. Chemokines and HIV–1 second receptors , 1996, Nature Medicine.
[10] D. Weissman,et al. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[11] F. Buseyne,et al. Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells. , 1996, Virology.
[12] C. Walker,et al. RANTES, MIP-1α and MIP-1β are not involved in the inhibition of HIV-1SF33 replication mediated by CD8+ T-cell clones , 1996 .
[13] M. Bukrinsky,et al. Chemokines and HIV replication , 1996, Nature.
[14] J. Levy,et al. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. , 1996, Immunology today.
[15] A. Lanzavecchia,et al. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy , 1996, The Journal of experimental medicine.
[16] D. Taub,et al. β Chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production , 1996, Journal of leukocyte biology.
[17] S. Arya,et al. Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.
[18] M. Barnardo,et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). , 1995, Tissue antigens.
[19] J. Sheridan,et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. , 1995, Science.
[20] D. Taub,et al. CD8+ and CD45RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin‐8 and RANTES , 1995, European journal of immunology.
[21] B. Dewald,et al. Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.
[22] S. Rowland-Jones,et al. An antigen processing polymorphism revealed by HLA‐B8‐restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism , 1993, European Journal of Immunology.
[23] D. Goeddel,et al. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes , 1993, The Journal of experimental medicine.
[24] B. Walker,et al. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens , 1993, Journal of virology.
[25] S. Burrows,et al. Peptide epitope induced apoptosis of human cytotoxic T lymphocytes. Implications for peripheral T cell deletion and peptide vaccination. , 1993, Journal of immunology.
[26] D. Richman,et al. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[27] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[28] E A Emini,et al. Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors , 1991, Journal of virology.
[29] D. Nixon,et al. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides , 1988, Nature.